Rubió Metabolomics is a biotechnology company based in Spain that has been making waves since its establishment in 2004. The company is a part of the Rubió Group and specializes in the field of Metabolomics. Its slogan, "OWL is a biotechnology company leader in the field of Metabolomics, with diagnostics products and unique R&D services," reflects its commitment to innovative and unique offerings in the biotechnology and life sciences industries. Rubió Metabolomics differentiates itself by offering diagnostic tests with cutting-edge technologies, as well as R&D services to the scientific community and industry leveraging the power of metabolomics. The company's most recent investment was from Kereon Partners in a Venture Round investment on 01 January 2015, showcasing the confidence of investors in the company's potential for growth and innovation. Overall, Rubió Metabolomics stands out as a pioneering biotechnology company that continues to capture attention and investment in the biotechnology and life sciences sectors due to its unique approach to Metabolomics, diagnostic products, and R&D services.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Venture Round | Unknown | 1 | Kereon Partners | 01 Jan 2015 |
No recent news or press coverage available for Rubió Metabolomics.